Form CORRESP - Correspondence:
SEC Accession No. 0001437749-21-012911
Filing Date
2021-05-20
Accepted
2021-05-20 16:14:50
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 6766
2 img01.jpg GRAPHIC 4321
  Complete submission text file 0001437749-21-012911.txt   13844
Mailing Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017
Business Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

EIN.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2835 In Vitro & In Vivo Diagnostic Substances